Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Complete Title: A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1133 in Patients with Advanced Solid Tumors Harboring a KRAS G12D Mutation
Trial Phase: I/II
Investigator: Gabriela Chiorean
This is a Phase 1/2, open-label, multicenter, study evaluating the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1133 in patients with advanced solid tumor malignancy harboring a KRAS G12D mutation.
Keywords:
- Pancreatic Cancer
- Solid Tumors
- Lung Carcinoma, Non-Small-Cell (NSCLC)
- Colorectal Neoplasms
- Advanced Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
I/II
Gabriela Chiorean
RG1123417
NCT05737706
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1133 in Patients with Advanced Solid Tumors Harboring a KRAS G12D Mutation
Pancreatic Cancer
Solid Tumors
Lung Carcinoma, Non-Small-Cell (NSCLC)
Colorectal Neoplasms
Advanced Solid Tumors